Furthermore, extracellular NDKA protein activates mitogen-activated protein kinase (MAPK) pathways in myeloid leukemia cells, which include extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 signaling molecules [55]. The gene discussed is WNK2; the disease is myeloid leukemia.